Oxford Ledge
Search
Microbot Medical Inc. (NASDAQ: MBOT) is a $20M medical - instruments & supplies company trading at $1.71. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:42 UTC.
Microbot is a medical device company developing robotic systems for minimally invasive endovascular surgery. The company's primary product is the LIBERTY Endovascular Robotic Surgical System, an FDA-cleared, fully disposable robot designed to remotely manipulate guidewires and catheters within blood vessels, particularly targeting the peripheral vasculature market. The LIBERTY system is compact and mobile, reducing the need for dedicated surgical rooms and extensive capital equipment, while providing operators protection from radiation exposure.
Summarized from Microbot Medical Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
| Quote | |
| Price | $1.71 |
| Market cap | $20M |
| Volume | 87.0K shares |
| Valuation | |
| EV/EBITDA | 9.60× |
| Return on equity | 1,439.06% |
Microbot is a medical device company developing robotic systems for minimally invasive endovascular surgery.
MBOT trades at $1.71, 9.60× EV/EBITDA, as of 2026-10-11.
Microbot Medical Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-21. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:42 UTC. This page is also available as JSON at /api/data?ticker=MBOT and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for MBOT and 5,000+ tickers.
Create a free account — keep MBOTGET /api/data?ticker=MBOT
This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt